Skip to main content

Day: March 28, 2025

Safety Shot, Inc. Announces Record Date for Spin-Off and Distribution of Shares Common Stock of Caring Brands, Inc. – Updated

JUPITER, FL, March 28, 2025 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”), today announced that the record date for the spin-off and distribution of shares of common stock, par value $0.0001 per share, (“Caring Brands Common Stock”), of Caring Brands, Inc. (“CABR”), currently a subsidiary of the Company, has been set for April 7, 2025 (the “Record Date”). Stockholders of the Company and holders of certain warrants issued in the Company’s public offering in July 2021 (the “Warrants”) will receive one share of Caring Brands Common Stock, for every 45 shares of the Company’s common stock held or underlying the Warrants as of the Record Date. Fractional shares of Caring Brands Common Stock will not be distributed. Instead, ClearTrust, LLC the distribution agent, will round down fractional shares...

Continue reading

Senvest Capital Reports Results for the Year Ended December 31, 2024

MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. today reported net income attributable to common shareholders of $258.1 million or $105.06 per share for the year ended December 31, 2024. This compares to net income attributable to common shareholders of $83.6 million or $33.78 per share for the year 2023. Financial statements are available online at Sedar www.sedarplus.ca  CONSOLIDATED STATEMENTS OF INCOME  (in millions of dollars, except per share amounts)  For the years ended       December 31, 2024 December 31, 2023     Net income attributable to common shareholders $258.1 $83.6     Diluted earnings per share attributable to common shareholders $105.06 $33.78     Contact: George Malikotsis, Vice President Finance(514) 281-8082

Continue reading

Summit State Bank Reports Revised Fourth Quarter 2024 Financial Results

SANTA ROSA, Calif., March 28, 2025 (GLOBE NEWSWIRE) — Summit State Bank (the “Bank”) (Nasdaq: SSBI) today reported that it has revised its fourth quarter and full year 2024 financial results from those announced in the press release dated January 28, 2025. In connection with the preparation and review of its 2024 financial statements, the Bank has concluded it is necessary to record a $693,000 other real estate owned valuation adjustment, a $146,000 increase in reserve for unfunded loans, and a $76,000 credit loss provision reversal for the fourth quarter 2024. The need for the valuation adjustment results from an updated appraisal report obtained in the first quarter of 2025. The additional reserve for unfunded loans and provision reversal results from the Bank’s adoption of a new CECL model as of December 31, 2024. The valuation...

Continue reading

Avista reaches all-party, all issues settlement in Oregon general rate case

If approved, new rates would take effect beginning September 1, 2025 SPOKANE, Wash., March 28, 2025 (GLOBE NEWSWIRE) — Avista (NYSE: AVA), the Staff of the Public Utility Commission of Oregon (Commission), the Oregon Citizens’ Utility Board (“CUB”), Alliance of Western Energy Consumers (“AWEC”), and the joint intervenor Climate Solutions/Green Energy Institute at Lewis & Clark Law School, parties to the Company’s natural gas general rate case, have reached a settlement agreement that has been submitted to the Commission for its consideration, and which would resolve all issues in the proceeding. If approved, this settlement would result in a base revenue increase of $4.2 million, as compared to Avista’s original request of $7.8 million. The agreed-upon revenue requirement is predicated on a proposed rate of return of 7.219%...

Continue reading

Knight Therapeutics Inc. ranks on The Globe and Mail’s sixth-annual Women Lead Here benchmark of executive gender diversity

MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2025 Report on Business magazine’s sixth annual Women Lead Here list. This annual editorial benchmark identifies top-level Canadian businesses with the highest executive gender diversity. “We are both proud and humble to have Knight Therapeutics Inc. once again featured on the Globe and Mail’s Report on Canada’s Women Lead Here, as one of the top companies for executive gender diversity within the Canadian corporate landscape and specialty pharmaceutical sector,” said Samira Sakhia, President and Chief Executive Officer of Knight. “A culture of diversity is at the core of Knight’s values, and we remain committed to fostering these principles every day, both...

Continue reading

Purpose Investments Inc. Announces 2025 First-Quarter Distributions for Purpose Specialty Lending Trust

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the 2025 first-quarter distributions for Purpose Specialty Lending Trust.  TickerSymbol Distributionpershare/unit ExDistributionDate RecordDate PayableDatePurpose Specialty Lending Trust – Class A Unlisted $0.1215 03/31/2025 03/31/2025 04/22/2025Purpose Specialty Lending Trust – Class F Unlisted $0.1255 03/31/2025 03/31/2025 04/22/2025Purpose Specialty Lending Trust – Class U Unlisted US $0.1665 03/31/2025 03/31/2025 04/22/2025Purpose Specialty Lending Trust – Class A1, Series 2 Unlisted $0.1405 03/31/2025 03/31/2025 04/22/2025Purpose Specialty Lending Trust – Class F, Series 3 Unlisted $0.1455 03/31/2025 03/31/2025 04/22/2025About Purpose Investments Inc. Purpose Investments Inc. is an asset management company with...

Continue reading

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress

$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business development related activities and other strategic alternatives BOSTON, March 28, 2025 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the year ended December 31, 2024. Full Year 2024 Financial Results As of December 31, 2024 and December 31, 2023, the company had cash, cash equivalents and marketable securities totaling $171.4 million and $303.5 million, respectively. Research and development expenses for the fourth quarter 2024 were $9.2 million and $78.2 million for the...

Continue reading

WF Holding Limited Announces Closing of Initial Public Offering

KUALA LUMPUR, March 28, 2025 (GLOBE NEWSWIRE) — WF Holding Limited (“WF Holding” or “Company”), a Malaysia-based manufacturer of fiberglass reinforced plastic (FRP) products, announced today the successful closing of its initial public offering of 2,000,000 ordinary shares, par value $0.00005 per share (the “Ordinary Shares”), at a public offering price of $4.00 per share. The offering generated total gross proceeds of $8 million, before deducting underwriting discounts and other offering expenses. The Company’s Ordinary Shares started trading on the Nasdaq Capital Market on March 27, 2025 under the ticker symbol “WFF.” In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 Ordinary Shares at the public offering price, less underwriting discounts. The Company intends to use...

Continue reading

Token Cat Limited Announces Filing of its Annual Report on Form 20-F

BEIJING, March 28, 2025 (GLOBE NEWSWIRE) — Token Cat Limited (“Token Cat” or the “Company”) (NASDAQ: TC), a leading automotive marketplace in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission (the “SEC”) on March 28, 2025. The annual report, which contains the Company’s audited consolidated financial statements, can be accessed on the Company’s investor relations website at https://ir.tuanche.com/ or the SEC’s website at https://www.sec.gov/. The Company will provide a hard copy of the annual report, free of charge, to its shareholders and American Depositary Share holders upon request. About Token Cat Limited Founded in 2010, Token Cat Limited, formerly known as TuanChe...

Continue reading

Markforged Announces Fourth Quarter and Full Year 2024 Results

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) — Markforged Holding Corporation (NYSE: MKFG) (“Markforged”), the company strengthening manufacturing resiliency by enabling industrial production at the point of need, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Results Compared To Fourth Quarter 2023Revenue was $22.4 million compared to $24.2 million. Gross margin was 44.8% compared to 48.4%. Non-GAAP gross margin was 46.4% compared to 49.5%. Operating expenses were $25.0 million compared to $31.1 million. Non-GAAP operating expenses were $19.9 million compared to $24.9 million. Net loss was $11.9 million compared to net loss of $14.2 million. Non-GAAP net loss was $9.0 million compared to a loss of $11.6 million. Cash and cash equivalents, including...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.